Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mtb72F/AS02A Vaccine in Healthy PPD-Positive Adults
NCT00146744Phase 2Completed
- Sponsor
- GSK
- Start
- Jul 2005
- Primary completion
- May 2006
- Modality
- Recombinant Proteins and Enzymes, Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of Mtb72F/AS02A in Tuberculosis (TB), sponsored by GSK. Started Jul 2005; status: completed.
02
Drugs
Mtb72F/AS02A
03
Conditions
Tuberculosis (TB)
Beyond the preview
Go deeper on NCT00146744.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00146744.